CENTURY THERAPEUTICS INC
IPSCNASDAQ🏆 #2465 by market capEarnings Aug 13 · PreUS Equity
$271.21▼ $19.28 (−7.11%)
Simulated price1h—
24h▼ 7.1%
7d—
14d—
30d—
1y—
🏦Market Cap
$357M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
3.1x
Fair
Otter Score
41
Weak
No chart data available for IPSC.
Trading Snapshot
- Day Range
- $268.57 – $275.37
- 52-Week Range
- $0.44 – $3.04
- Volume
- $1.58B
- Avg Volume
- $1.90B
- Shares Outstanding
- 180.3M
- Next Earnings
- Sep 2, 2026
Fundamentals Snapshot
- Annual Revenue
- $115M
- Last Q Revenue
- $27M
- P/E Ratio
- —
- P/S Ratio
- 3.1x
- EPS (TTM)
- $-1.11
- Dividend Yield
- —
Why Investors Own IPSC
- ✓High-growth profile — revenue up +8.8% YoY with expanding US Equity exposure.
- ✓Healthy economics — 60% gross margin and 9% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$115M▲ +7.4% YoY
Gross Margin (TTM)
59.6%▲ +2.9% YoY
Operating Income (TTM)
$15M▲ +7.4% YoY
Free Cash Flow (TTM)
$10M▲ +7.4% YoY
About CENTURY THERAPEUTICS INC
A company profile for CENTURY THERAPEUTICS INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
41/100
Analyst Price Target
ⓘAverage Target
$328.95
▲ +21.3% Upside
High Target$362.17
Low Target$277.82
Based on 12 analysts
Latest News & Updates
🚀
MarketWatch·2h ago
CENTURY THERAPEUTICS INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
MarketWatch·5h ago
Analysts lift IPSC price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
Reuters·1d ago
CENTURY THERAPEUTICS INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.